YALINGYANGYALING YANG11801YANG, YALINGInstructorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson22903157Redis RS, Calin S, Yang Y, You MJ, Calin GAPharmacology & therapeuticsCell-to-cell miRNA transfer: from body homeostasis to therapy. Pharmacol Ther. 2012 Nov; 136(2):169-74.Pharmacol Ther2012-08-08T00:00:002012Cell-to-cell miRNA transfer: from body homeostasis to therapy.Experimental TherapeuticsHematopathologyLeukemiaLymphoma-MyelomaMD AndersonCHENG CAMERONYINCHENG CAMERON YIN9090YIN, CHENG CAMERONAssociate ProfessorHAGOP MKANTARJIANHAGOP M KANTARJIAN8501KANTARJIAN, HAGOP MProfessorRAJYALAKSHMILUTHRARAJYALAKSHMI LUTHRA8592LUTHRA, RAJYALAKSHMIProfessorFREDRICK BHAGEMEISTERFREDRICK B HAGEMEISTER8570HAGEMEISTER, FREDRICK BProfessorL JEFFREYMEDEIROSL JEFFREY MEDEIROS8762MEDEIROS, L JEFFREYProfessorELIAS JOSEPHJABBOURELIAS JOSEPH JABBOUR9124JABBOUR, ELIAS JOSEPHAssociate ProfessorGEORGE ACALINGEORGE A CALIN9408CALIN, GEORGE AProfessorNITINJAINNITIN JAIN9432JAIN, NITINAssistant Professor11886011Barista I, Cabanillas F, Romaguera JE, Khouri IF, Yang Y, Smith TL, Strom SS, Medeiros LJ, Hagemeister FBAnnals of oncology : official journal of the European Society for Medical OncologyIs there an increased rate of additional malignancies in patients with mantle cell lymphoma? Ann Oncol. 2002 Feb; 13(2):318-22.Ann Oncol2002-02-01T00:00:002002Is there an increased rate of additional malignancies in patients with mantle cell lymphoma?74Professor10Assistant Professor54Instructor14Associate Professor1515 Holcombe Blvd.Houston77030TX0.1165640.0032809329research areas0.11160.01345987coauthor of1.774030.18135660similar to113selected publicationsAuthorship 3736557Authorship 3736785Authorship 3736973D017467Chemicals & Drugs34700.967946Receptors, ErythropoietinD002883Anatomy1282720.869085Chromosomes, Human, Pair 14D002888Anatomy911430.937414Chromosomes, Human, Pair 19D007143Chemicals & Drugs1012470.899516Immunoglobulin Heavy ChainsD022761Physiology35570.974094Gene Transfer, Horizontaltrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Assistant ProfessorAssistant Professortrue1InstructorInstructortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professor24030742Jaso JM, Yin CC, Lu VW, Zhao M, Abruzzo LV, You MJ, Yang Y, Luthra R, Medeiros LJ, Lu GModern pathology : an official journal of the United States and Canadian Academy of Pathology, IncB acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease. Mod Pathol. 2014 Mar; 27(3):382-9.Mod Pathol2013-09-13T00:00:002013B acute lymphoblastic leukemia with t(14;19)(q32;p13.1) involving IGH/EPOR: a clinically aggressive subset of disease.